Please login to read the full article.
Scrip Regulatory Affairs
Commission consults on plans to ensure EU-wide equivalence of imported active substances
09 December 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Commission consults on API quality template for foreign manufacturers exporting to EU
- Commission consults on GMP rules for active substances under EU falsified medicines legislation
- Commission consults on unique identifiers mandated by EU falsified medicines law
- EMA proposes to update qualified persons requirements on drug certification, batch release
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
